No matter how cynical the overall market is, Abbott Laboratories (ABT) performance over the last week is recorded -1.70%

On Monday, Abbott Laboratories (NYSE: ABT) opened lower -0.69% from the last session, before settling in for the closing price of $113.83. Price fluctuations for ABT have ranged from $99.71 to $121.64 over the past 52 weeks.

During the last 5-year period, the sales growth of Healthcare Sector giant was 6.54%. Company’s average yearly earnings per share was noted 5.31% at the time writing. With a float of $1.72 billion, this company’s outstanding shares have now reached $1.73 billion.

Let’s determine the extent of company efficiency that accounts for 114000 employees. In terms of profitability, gross margin is 54.7%, operating margin of 16.73%, and the pretax margin is 16.44%.

Abbott Laboratories (ABT) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Abbott Laboratories is 0.66%, while institutional ownership is 76.58%. The most recent insider transaction that took place on Nov 04 ’24, was worth 1,800,000. Before that another transaction happened on Oct 21 ’24, when Company’s EXECUTIVE VICE PRESIDENT sold 157,421 for $117.04, making the entire transaction worth $18,424,298. This insider now owns 184,806 shares in total.

Abbott Laboratories (ABT) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 5.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.15% during the next five years compared to 19.65% growth over the previous five years of trading.

Abbott Laboratories (NYSE: ABT) Trading Performance Indicators

Check out the current performance indicators for Abbott Laboratories (ABT). In the past quarter, the stock posted a quick ratio of 1.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.76. Likewise, its price to free cash flow for the trailing twelve months is 30.23.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.29, a number that is poised to hit 1.34 in the next quarter and is forecasted to reach 5.16 in one year’s time.

Technical Analysis of Abbott Laboratories (ABT)

Looking closely at Abbott Laboratories (NYSE: ABT), its last 5-days average volume was 4.2 million, which is a drop from its year-to-date volume of 4.67 million. As of the previous 9 days, the stock’s Stochastic %D was 33.20%. Additionally, its Average True Range was 1.70.

During the past 100 days, Abbott Laboratories’s (ABT) raw stochastic average was set at 40.11%, which indicates a significant increase from 37.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.33% in the past 14 days, which was lower than the 15.76% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $115.40, while its 200-day Moving Average is $110.53. However, in the short run, Abbott Laboratories’s stock first resistance to watch stands at $113.94. Second resistance stands at $114.84. The third major resistance level sits at $115.41. If the price goes on to break the first support level at $112.46, it is likely to go to the next support level at $111.89. Now, if the price goes above the second support level, the third support stands at $110.99.

Abbott Laboratories (NYSE: ABT) Key Stats

There are currently 1,734,455K shares outstanding in the company with a market cap of 196.06 billion. Presently, the company’s annual sales total 40,109 M according to its annual income of 5,723 M. Last quarter, the company’s sales amounted to 10,635 M and its income totaled 1,646 M.